SCHEDULE 13G/A: Royce & Associates LP Discloses 4.99% Stake in Mesa Laboratories, Inc.

Royce & Associates LP has filed an amended Schedule 13G, reporting a 4.99% beneficial ownership stake in Mesa Laboratories, Inc. as of March 31, 2025.

Summary

• Royce & Associates LP, an investment adviser, has filed an Amendment No. 13 to Schedule 13G regarding its beneficial ownership in Mesa Laboratories, Inc.
• As of March 31, 2025, Royce & Associates LP beneficially owns 271,118 shares of Mesa Laboratories, Inc. Common Stock.
• This ownership represents 4.99% of the class of securities.
• Royce & Associates LP holds sole voting power and sole dispositive power over all 271,118 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• Royce & Associates LP is an indirect majority-owned subsidiary of Franklin Resources, Inc. (FRI) and exercises investment discretion and voting power independently from FRI and its other affiliates.
• Royce & Associates LP disclaims any pecuniary interest in the reported securities and disclaims being a 'beneficial owner' as defined in Rule 13d-3, or a 'group' with FRI affiliates or Principal Shareholders.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative performance indicators or forward-looking statements from the issuer.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect."

Industry Context

This filing is a routine disclosure of a significant ownership stake by an investment adviser in a publicly traded company. It does not provide broader industry trends but indicates continued investment interest in Mesa Laboratories, Inc. by a notable asset manager.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, confirming their continued holding below the 5% threshold for a 13G filing.

Key Dates

Keywords

Mesa Laboratories Inc., Royce & Associates LP, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Ownership Disclosure, 59064R109